Back
AstraZeneca PLC 10K Form
Buy
64
AZN
AstraZeneca PLC
Last Price:
$77.59
Seasonality Move:
6.86%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive AZN News And Ratings
See the #1 stock for the next 7 days that we like better than AZN
AZN Financial Statistics
Sales & Book Value
| Annual Sales: | $54.1B |
|---|---|
| Cash Flow: | $2B |
| Price / Cash Flow: | 33.3 |
| Annual Sales: | $13.15 |
| Price / Book: | 5.91 |
Profitability
| EPS (TTM): | 2.25500 |
|---|---|
| Net Income (TTM): | $7B |
| Gross Margin: | $43.9B |
| Return on Equity: | 17.77% |
| Return on Assets: | 6.77% |
AstraZeneca PLC Earnings Forecast
Key AstraZeneca PLC Financial Ratios
-
The Gross Profit Margin over the past 27 years for AZN is 81.12%.
-
The Selling, General & Administrative Expenses for AZN have been equal to 37.40% of Gross Profit Margin.
-
The Research & Development expenses have been 25.12% of Revenue.
-
The Interest Expense is 23.91% of Operating Income.
-
The Net Earning history of AZN is 13.01% of Total Revenues.
-
Per Share Earnings over the last 35 years have been positive in 21 years.
AstraZeneca PLC Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | AZN |
| CUSIP: | 046353 |
| Website: | astrazeneca.com |
Debt
| Debt-to-Equity Ratio: | 0.7 |
|---|---|
| Current Ratio: | 0.93 |
| Quick Ratio: | 0.74 |
Price-to-Earnings
| Trailing P/E Ratio: | 34.49 |
|---|---|
| Forward P/E Ratio: | 15.31 |
AZN Technical Analysis vs Fundamental Analysis
Buy
64
AstraZeneca PLC (AZN)
is a Buy
Is AstraZeneca PLC a Buy or a Sell?
-
AstraZeneca PLC stock is rated a BuyThe current AstraZeneca PLC [AZN] share price is $77.60. The Score for AZN is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.